Fischbach-Teschl appointed next director of Meinig School

Claudia Fischbach-Teschl, the Stanley Bryer 1946 Professor of Biomedical Engineering, has been appointed as the next director of the Nancy E. and Peter C. Meinig School of Biomedical Engineering. Her initial three-year term will begin on July 1, 2024.

"Claudia has been an exemplary faculty member, leader, collaborator and community member from the moment she arrived at Cornell in 2007," said Lynden Archer, the Joseph Silbert Dean of Engineering, in a message to the engineering community. "Her contributions have been awarded with the college's highest recognitions for research excellence, teaching excellence, and — most recently — for embodying our core values through the EPICC award."

Fischbach-Teschl's research uses engineering approaches to provide molecular-scale, mechanistic insights into how tumor-microenvironment interactions regulate cancer development, progression, and therapy resistance with a focus on cell-ECM interactions. Beginning in 2016, she led Cornell’s Physical Sciences Oncology Center on the Physics of Cancer Metabolism, and she recently served as associate director of the Cornell Nanoscale Science and Engineering Facility.

She received her Ph.D. in pharmaceutical technology from the University of Regensburg, Germany, and conducted her postdoctoral work at Harvard University in the Division of Engineering and Applied Sciences. Throughout her career, she has received numerous honors. She is a fellow of the American Institute for Medical and Biological Engineering, the Biomedical Engineering Society, and the Alexander von Humboldt Foundation in Germany.

"The beginning of Claudia’s term will mark the completion of an incredible decade of service by Marjolein van der Meulen, the current James M. and Marsha McCormick Director of Biomedical Engineering," Archer said. "This year marks only the 20th anniversary since the formation of a biomedical engineering department at Cornell. The school's growth — in size, impact, and reputation — in these last 10 years is a reflection of Marjolein's exemplary leadership."

Archer added that he looks forward to working with Fischbach-Teschl to continue building upon the current momentum of the Meinig School, including strengthening its connections to Weill Cornell Medicine through the Engineering Innovations in Medicine initiative.

Other Articles of Interest